The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants

The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants

Abstract. Background. Anticoagulants are promising regimens for treating coronavirus disease 2019 (COVID-19). However, whether prophylactic or intermediate-to-therapeutic dosage is optimal remains under active discussion. Methods. We comprehensively searched PubMed, Embase, Scopus, Web of Science, C...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingyue Guo, Qi Han, Jiaxuan Xing, Feng Xu, Jiali Wang, Chuanbao Li, Zechen Shan, Yuan Bian, Hao Wang, Li Xue, Qiuhuan Yuan, Chang Pan, Yanshan De, Xingfang Wang, Panpan Hao, Shengchuan Cao, Jiaojiao Pang, Yuguo Chen
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2022-09-01
Series:Emergency and Critical Care Medicine
Online Access:http://journals.lww.com/10.1097/EC9.0000000000000059
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items